Showing results (61-70 of 435) with videos related to
Sort By:
Pageof 44
Cell Death and Differentiation|June 26, 2001
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cellsL Tentori, I Portarena, E Bonmassar, et al.Journal of the National Cancer Institute|January 1, 1976
Antigenic changes of L5178Y lymphoma after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in vivoA Nicolin, F Spreafico, E Bonmassar, et al.International Journal of Immunopharmacology|February 1, 1993
Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cellsC D'Onofrio, O Franzese, F Ricci, et al.International Journal of Immunopharmacology|January 1, 1990
IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitroL Tentori, C Leonetti, G Lanzilli, et al.Chemical Immunology and Allergy|September 20, 2008
Immune regulation and tolerance to fungi in the lungs and skinL Romani, P PuccettiArzneimittel-Forschung|January 1, 1980
Adamantane derivatives of biological interest. Synthesis and antiviral activity of 2-(1-adamantyl)imidazole derivativesR Pellicciari, M C Fioretti, P Cogolli, et al.International Journal of Immunopharmacology|January 1, 1991
Modulation of circulating colony-stimulating activity in mice: combined effects of IL-1 and bacterial or indomethacin treatmentF Campanile, L Binaglia, M C Fioretti, et al.Pharmacological Research|July 1, 1990
Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-IB Macchi, C D'Onofrio, R A Labianca, et al.International Journal of Immunopharmacology|July 1, 1993
Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotidesU Grohmann, L Binaglia, P Puccetti, et al.Anticancer Research|December 22, 1998
2'-2'-difluorodeoxycytidine: in vitro effects on cell-mediated immune responseE Alvino, M P Fuggetta, M Tricarico, et al.Pageof 44